INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,411,956 | +51.8% | 95,523 | +26.9% | 0.31% | +57.1% |
| Q2 2023 | $1,588,682 | +19.1% | 75,293 | -3.7% | 0.20% | +8.9% |
| Q1 2023 | $1,333,412 | -15.0% | 78,206 | -0.5% | 0.18% | -23.1% |
| Q4 2022 | $1,569,629 | -14.4% | 78,560 | -7.7% | 0.23% | -15.8% |
| Q3 2022 | $1,833,000 | +90.5% | 85,092 | +74.4% | 0.28% | +98.6% |
| Q2 2022 | $962,000 | -22.7% | 48,781 | -7.9% | 0.14% | +1.4% |
| Q1 2022 | $1,244,000 | -45.1% | 52,945 | -36.4% | 0.14% | -28.1% |
| Q4 2021 | $2,268,000 | -2.8% | 83,251 | -1.8% | 0.19% | -6.8% |
| Q3 2021 | $2,334,000 | -5.4% | 84,754 | -2.3% | 0.21% | -4.6% |
| Q2 2021 | $2,468,000 | -24.4% | 86,716 | -9.6% | 0.22% | -28.9% |
| Q1 2021 | $3,266,000 | -0.5% | 95,907 | -2.7% | 0.30% | +5.2% |
| Q4 2020 | $3,281,000 | -15.9% | 98,545 | -18.8% | 0.29% | -4.9% |
| Q3 2020 | $3,901,000 | +11.8% | 121,360 | -4.2% | 0.30% | +3.8% |
| Q2 2020 | $3,489,000 | – | 126,682 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |